Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)

Frequently, the number of circulating tumor cells (CTC) isolated in 7.5 mL of blood is too small to reliably determine tumor heterogeneity and to be representative as a “liquid biopsy”. In the EU FP7 program CTCTrap, we aimed to validate and optimize the recently introduced Diagnostic LeukApheresis...

Descripción completa

Detalles Bibliográficos
Autores principales: Andree, Kiki C., Mentink, Anouk, Zeune, Leonie L., Terstappen, Leon W.M.M., Stoecklein, Nikolas H., Neves, Rui P., Driemel, Christiane, Lampignano, Rita, Yang, Liwen, Neubauer, Hans, Fehm, Tanja, Fischer, Johannes C., Rossi, Elisabetta, Manicone, Mariangela, Basso, Umberto, Marson, Piero, Zamarchi, Rita, Loriot, Yohann, Lapierre, Valerie, Faugeroux, Vincent, Oulhen, Marianne, Farace, Françoise, Fowler, Gemma, Sousa Fontes, Mariane, Ebbs, Berni, Lambros, Maryou, Crespo, Mateus, Flohr, Penny, de Bono, Johann S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Tumor Markers and Signatures
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637919/
https://www.ncbi.nlm.nih.gov/pubmed/30006930
http://dx.doi.org/10.1002/ijc.31752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637919/
https://www.ncbi.nlm.nih.gov/pubmed/30006930
http://dx.doi.org/10.1002/ijc.31752

Ejemplares similares